Premium
Arginine methyltransferase CARM1 is a promoter‐specific regulator of NF‐κB‐dependent gene expression
Author(s) -
Covic Marcela,
Hassa Paul O,
Saccani Simona,
Buerki Christine,
Meier Nadja I,
Lombardi Cornelia,
Imhof Ralph,
Bedford Mark T,
Natoli Gioacchino,
Hottiger Michael O
Publication year - 2005
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.1038/sj.emboj.7600500
Subject(s) - library science , biomedicine , biology , genetics , computer science
Nuclear factor kappaB (NF‐κB) plays an important role in the transcriptional regulation of genes involved in inflammation and cell survival. Here, we show that coactivator‐associated arginine methyltransferase CARM1/PRMT4 is a novel transcriptional coactivator of NF‐κB and functions as a promoter‐specific regulator of NF‐κB recruitment to chromatin. Carm1 knockout cells showed impaired expression of a subset of NF‐κB‐dependent genes upon TNFα or LPS stimulation. CARM1 forms a complex with p300 and NF‐κB in vivo and interacts directly with the NF‐κB subunit p65 in vitro . CARM1 seems to act in a gene‐specific manner mainly by enhancing NF‐κB recruitment to cognate sites. Moreover, CARM1 synergistically coactivates NF‐κB‐mediated transactivation, in concert with the transcriptional coactivators p300/CREB‐binding protein and the p160 family of steroid receptor coactivators. For at least a subset of CARM1‐dependent NF‐κB target genes, the enzymatic activities of both CARM1 and p300 are necessary for the observed synergy between CARM1 and p300. Our results suggest that the cooperative action between protein arginine methyltransferases and protein lysine acetyltransferases regulates NF‐κB‐dependent gene activation in vivo .